NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/06/2024
Back to search
Official data from USPTO
THE BRIDGE HATTR AMYLOIDOSIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
09/06/2024
Trademark type
Combined
Nice classes
35, 41, 44
Filing date
02/13/2018
Registration date
01/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/06/2024
Last transaction
09/06/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/30/2017
First use in commerce
06/30/2017
Drawing code
3
Owner type
03
Owner location
Cambridge, MA, US
Examiner
HERRERA-MARCUS, ROSELLE MORALDE
Current location
Historical data usage
Mark description
The mark consists of the word "THE" located to the left of the design of a bridge, both located over the word "BRIDGE". Under the word "BRIDGE" is a horizontal line, and under that are the words "HATTR AMYLOIDOSIS".
Holders and representatives
Holders
Alnylam Pharmaceuticals, Inc.
Representatives
Sarah Anne Keefe Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 35Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness about hATTR amyloidosis among affected individuals and their families
Class 41
educational servicesproviding education information for training medical professionals and patients regarding hereditary ATTR (hATTR) amyloidosisdistributing course materials in connection therewith
Class 44
Providing medical information about hereditary ATTR (hATTR) amyloidosis
Publications
History of USPTO decisions and trademark events.
30 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/06/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/20/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/29/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/30/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/23/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/23/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/23/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/23/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/13/2018
PUBO
PUBLISHED FOR OPPOSITION
11/13/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/24/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/11/2018
ALIE
ASSIGNED TO LIE
10/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/07/2018
GNRT
NON-FINAL ACTION E-MAILED
04/07/2018
CNRT
NON-FINAL ACTION WRITTEN
04/07/2018
DOCK
ASSIGNED TO EXAMINER
03/29/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/22/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/21/2018
NWAP
NEW APPLICATION ENTERED
02/16/2018
Continuous trademark protection
Get notified about every new filing that threatens THE BRIDGE HATTR AMYLOIDOSIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.